LTI-291 is an activator of glucocerebrosidase (Gcase) extracted from patent WO 2017192841 A1.
References:
[1]. Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1.
















